These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19749223)

  • 1. Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas.
    Hu LS; Baxter LC; Pinnaduwage DS; Paine TL; Karis JP; Feuerstein BG; Schmainda KM; Dueck AC; Debbins J; Smith KA; Nakaji P; Eschbacher JM; Coons SW; Heiserman JE
    AJNR Am J Neuroradiol; 2010 Jan; 31(1):40-8. PubMed ID: 19749223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
    Hu LS; Baxter LC; Smith KA; Feuerstein BG; Karis JP; Eschbacher JM; Coons SW; Nakaji P; Yeh RF; Debbins J; Heiserman JE
    AJNR Am J Neuroradiol; 2009 Mar; 30(3):552-8. PubMed ID: 19056837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
    Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Xing Z; You RX; Li J; Liu Y; Cao DR
    Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic assessment of multi-echo dynamic susceptibility contrast MRI using a digital reference object.
    Stokes AM; Semmineh NB; Nespodzany A; Bell LC; Quarles CC
    Magn Reson Med; 2020 Jan; 83(1):109-123. PubMed ID: 31400035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of Arterial Spin Labeling in Comparison With Dynamic Susceptibility Contrast-Enhanced Perfusion for Brain Tumor Surveillance at 3T MRI.
    Lavrova A; Teunissen WHT; Warnert EAH; van den Bent M; Smits M
    Front Oncol; 2022; 12():849657. PubMed ID: 35669426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
    Paulson ES; Schmainda KM
    Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.
    Hu LS; Eschbacher JM; Dueck AC; Heiserman JE; Liu S; Karis JP; Smith KA; Shapiro WR; Pinnaduwage DS; Coons SW; Nakaji P; Debbins J; Feuerstein BG; Baxter LC
    AJNR Am J Neuroradiol; 2012 Jan; 33(1):69-76. PubMed ID: 22095961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading.
    Server A; Graff BA; Orheim TE; Schellhorn T; Josefsen R; Gadmar ØB; Nakstad PH
    Neuroradiology; 2011 Jun; 53(6):435-47. PubMed ID: 20857284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not.
    Boxerman JL; Schmainda KM; Weisskoff RM
    AJNR Am J Neuroradiol; 2006 Apr; 27(4):859-67. PubMed ID: 16611779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Single-Dose, Low-Flip-Angle-Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma.
    Anil A; Stokes AM; Karis JP; Bell LC; Eschbacher J; Jennings K; Prah MA; Hu LS; Boxerman JL; Schmainda KM; Quarles CC
    AJNR Am J Neuroradiol; 2024 Oct; 45(10):1545-1551. PubMed ID: 38782593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction.
    Gasparetto EL; Pawlak MA; Patel SH; Huse J; Woo JH; Krejza J; Rosenfeld MR; O'Rourke DM; Lustig R; Melhem ER; Wolf RL
    Radiology; 2009 Mar; 250(3):887-96. PubMed ID: 19244052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of single-dose, dual-echo based CBV threshold for fractional tumor burden mapping in recurrent glioblastoma.
    Anil A; Stokes AM; Chao R; Hu LS; Alhilali L; Karis JP; Bell LC; Quarles CC
    Front Oncol; 2023; 13():1046629. PubMed ID: 36733305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of cerebral gliomas using rCBV measurements during sequential acquisition of T1-perfusion and T2*-perfusion MRI.
    Saini J; Gupta RK; Kumar M; Singh A; Saha I; Santosh V; Beniwal M; Kandavel T; Cauteren MV
    PLoS One; 2019; 14(4):e0215400. PubMed ID: 31017934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.
    Gahramanov S; Muldoon LL; Li X; Neuwelt EA
    Radiology; 2011 Dec; 261(3):796-804. PubMed ID: 21940504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study.
    Chaskis C; Stadnik T; Michotte A; Van Rompaey K; D'Haens J
    Acta Neurochir (Wien); 2006 Mar; 148(3):277-85; discussion 285. PubMed ID: 16421765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
    Arvinda HR; Kesavadas C; Sarma PS; Thomas B; Radhakrishnan VV; Gupta AK; Kapilamoorthy TR; Nair S
    J Neurooncol; 2009 Aug; 94(1):87-96. PubMed ID: 19229590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.